A systematic review of the feasibility, acceptability, and efficacy of online supportive care interventions targeting men with a history of prostate cancer by Forbes, Cynthia C.. et al.
REVIEWS
A systematic review of the feasibility, acceptability, and efficacy
of online supportive care interventions targeting men with a history
of prostate cancer
Cynthia C. Forbes1,2 & Amy Finlay3 & Megan McIntosh3 & Shihab Siddiquee4 & Camille E. Short5
Received: 4 September 2018 /Accepted: 19 December 2018
# The Author(s) 2019
Abstract
Purpose To examine the feasibility, acceptability, and efficacy of online supportive care interventions targeting prostate cancer
survivors (PCS).
Methods Studies were identified through structured searches of PubMed, Embase and PsycINFO databases, and
bibliographic review. Inclusion criteria were (1) examined feasibility, acceptability, or efficacy of an online interven-
tion designed to improve supportive care outcomes for PCS; (2) presented outcome data collected from PCS
separately (if mixed cancer); and (3) evaluated efficacy outcomes using randomized controlled trial (RCT) design.
Results Sixteen studies met inclusion criteria; ten were classified as RCTs. Overall, 2446 men (average age 64 years) were
included. Studies reported on the following outcomes: feasibility and acceptability of an online intervention (e.g., patient support,
online medical record/follow-ups, or decision aids); reducing decisional conflict/distress; improving cancer-related distress and
health-related quality of life; and satisfaction with cancer care.
Conclusion We found good preliminary evidence for online supportive care among PCS, but little high level evi-
dence. Generally, the samples were small and unrepresentative. Further, inadequate acceptability measures made it
difficult to determine actual PCS acceptability and satisfaction, and lack of control groups precluded strong conclu-
sions regarding efficacy. Translation also appears minimal; few interventions are still publicly available. Larger trials
with appropriate control groups and greater emphasis on translation of effective interventions is recommended.
Implications for Cancer Survivors Prostate cancer survivors have a variety of unmet supportive care needs. Using online delivery
to improve the reach of high-quality supportive care programs could have a positive impact on health-related quality of life
among PCS.
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Introduction
Prostate cancer is the most prevalent cancer (excluding
nonmelanoma skins cancers) among men in many developed
countries around the world [1]. Advances in screening and
treatment technology in the past 30–40 years have significant-
ly improved the 5-year survival rate of prostate cancer from
around 68% to present rates of over 90% [2]. Though survival
rates are high, quality of life (QoL) during survivorship may
be poor. Prostate cancer treatment has been associated with
numerous physical and psychological short- and long-term
side-effects that have a significant impact on QoL [3, 4]. For
those men diagnosed with or having developed advanced
prostate cancer (with a 5-year survival rate of 29% [5]), the
effects of treatments and dealing with a poor prognosis have
even larger affects [6].
In fact, a large proportion of men with prostate cancer have
reported functional and psychosocial supportive care needs;
many of which are going unmet [7–9]. Supportive care needs
can be defined as the requirements for care during and after
treatments to help manage potential symptoms and side ef-
fects, help adaptation and coping, facilitate understanding
and inform decision-making, and reduce or minimize func-
tional declines [10]. A recent review examined the supportive
care needs of prostate cancer survivors and found some of the
most commonly reported are related to intimacy, information,
physical, and psychosocial needs [9]. A review of supportive
care interventions for men with prostate cancer concluded that
interventions with combinations of educational, cognitive-be-
havioral, communication, and peer support were generally
effective among intervention completers [11]. However, only
40% of interventions indicated acceptable mean attendance,
and one-quarter of intervention effects were moderated by
sociodemographic or psychosocial variables [11]. From a pub-
lic health point of view, this suggests the need to improve
intervention reach and adherence, while also ensuring inter-
ventions are sufficiently tailored to address unique needs,
which are influenced by individuals’ sociodemographic and
psychosocial profiles.
It has been suggested that utilizing online delivery of
supportive care interventions may help to improve
reach, while also allowing for high quality tailored care
at a low cost [12–15]. Firstly, online delivery allows
anonymity. This means men are able to share their feel-
ings or experience without fear of being emasculated
[16–18]. It also allows men to benefit from observing
discussions of others if they are not interested in active
participation [19, 20]. Secondly, online delivery can pro-
vide increased access to a multidisciplinary team of
health professionals, without the need to leave home.
This may be especially important for those living in
rural or remote areas, where access to urban treatment
centers can be difficult. Online delivery also affords the
convenience of participation at any time of day allowing
patients to access care outside of regular office hours
[21, 22]. Finally, compared with other distance-based
approaches (e.g., print-materials, DVDs, telephone
calls), online approaches have the capacity to provide
not only high-quality content, but also highly tailored
content. This, in addition to opportunities for interaction
with others and tools designed to support self-
management and decision-making [23] favors online
delivery.
Recent reviews have begun to examine the utility of tech-
nology and online delivery in follow-up and supportive care
interventions for cancer survivors [12, 13, 15]. While results
have been promising, the utility of online interventions for
supporting men with prostate cancer remains somewhat un-
clear. To date, reviews have focused on mixed cancer samples
only, and have not explored cancer type as a moderator or
reported prostate cancer specific results. This limits conclu-
sion regarding the acceptability, feasibility, and efficacy of
online supportive care interventions among men with prostate
cancer, especially given that breast cancer survivors are typi-
cally over represented. For example, recent reviews examined
the types and efficacy of online interventions that reported
QoL or QoL-related health outcomes and the effect of
eHealth in physical activity promotion among various cancer
survivor groups [15, 24]. McAlpine and colleagues advocate
for multidimensional interventions that incorporate methods
for educating participants and allowing participants to interact
with each other and health care providers [15]. However, of
the 14 studies they identified, only two reported results for
prostate cancer survivors [25, 26] and the review omitted
any descriptive feasibility and user acceptance (satisfaction)
data that was included in the studies. To inform the develop-
ment and or dissemination of online supportive care interven-
tions targeting men with prostate cancer a detailed synthesis of
the prostate cancer specific research is warranted.
This review aims to examine the feasibility, acceptabil-
ity, and efficacy of online supportive care interventions
targeting prostate cancer survivors. For the purpose of this
review, online supportive care interventions are defined as
interventions delivered via the internet (e.g., using a
website, tablet, or mobile app) with the aim of meeting
the informational, emotional, spiritual, social, and/or
physical needs of patients during their diagnostic, treat-
ment, or follow-up phase [27]. Patients are considered
prostate cancer survivors if they have ever received a
prostate cancer diagnosis. This includes those who are
on active surveillance, those treated with curative intent
and living disease free and those living with advanced
prostate cancer. As the main aim of this review is to ex-
amine the potential of online interventions for delivering
supportive care in any form, we have purposefully not
targeted a specific stage of disease or treatment.
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Method
The protocol for this review was registered a priori with
PROSPERO (ID CRD42017056319). The conduct and
reporting of the review adheres to the Preferred Reporting
Items for Systematic Reviews and Meta-analyses guidelines
[28]. A standardized form (based on ERC Cochrane template
for intervention reviews [29]) was used to extract and review
all data. A copy of the form is available via our open science
framework page (http://osf.io/unj5m).
Eligibility criteria
Inclusion and exclusion criteria were established a priori be-
fore conducting database searches. Studies were eligible for
inclusion if they (1) examined the feasibility, acceptability, or
efficacy of at least one online intervention designed to im-
prove supportive care outcomes for prostate cancer survivors
as a major part of the study; (2) presented outcome data col-
lected from prostate cancer survivors only; and (3) evaluated
efficacy outcomes using a randomized trial and/or feasibility/
acceptability using a single-arm or randomized trial design.
Studies were excluded if (1) they included mixed samples
(e.g., survivors and caregivers, or survivors of mixed cancer
types) and did not report study outcomes specifically for pros-
tate cancer survivors; (2) the intervention being evaluated was
targeted primarily at clinicians or caregivers rather than pros-
tate cancer survivors; (3) findings were only explored using
qualitative research methods; (4) findings were published in
any language other than English; or (5) if findings were avail-
able as a conference abstract only.
Search strategy
Studies were primarily identified through a structured search
of all publication years (until April 6, 2017) in the following
electronic databases: PubMed, Embase, and PsycINFO. The
search strategy was developed in consultation with a specialist
librarian at the University of Adelaide. Mesh terms in PubMed
and equivalent terms in other databases were identified and
used to search for all key concepts. Searches restricted to
abstract and title were also undertaken for selected keywords.
Boolean logic was used to combine the terms. The search
strategy was piloted and refined in each database to achieve
a balance between sensitivity (identifying high numbers of
relevant articles) and specificity (identifying a low number
of irrelevant articles) [30]. As a result, in PubMed and
Embase, search terms relating to prostate cancer AND ehealth
AND intervention evaluation AND supportive care outcomes
were searched. Whereas, in PsycINFO, only terms related to
prostate cancer AND ehealth AND intervention evaluation
were searched. The search terms used for each database are
detailed in additional file 1. The database searches were
conducted by a single author (CES). In addition to the data-
base search, endnote libraries of authors were reviewed and
citation chaining was employed to identify additional articles
of interest [30].
Study selection
All articles identified through the databases and hand searches
were imputed into a citation manager. Duplicate records were
then counted and removed. Two authors (CES and CF) inde-
pendently screened all articles against the inclusion and exclu-
sion criteria using a standardized form [29], taking title, ab-
stract, and full-text into account. Any disagreements were
discussed and resolved by consensus.
Data extraction
A data extraction form was developed by the research team to
extract information about the study setting, participant char-
acteristics, study design, intervention characteristics, data col-
lection methods, and findings relating to feasibility, accept-
ability, and efficacy of the intervention. Feasibility and accept-
ability data was extracted for all included studies were report-
ed. Efficacy data was only extracted for randomized trials. In
cases where pilot data and definitive RCT data were both
available (and focused on the same outcomes) only RCT data
was extracted. If findings were unclear based on results report-
ed in the manuscript, corresponding authors were emailed and
asked to provide clarification.
The extraction form followed a recommended template
[29] and was pilot tested by two reviewers (CF, CES) inde-
pendently (on three included articles) to ensure it captured all
relevant information and was easy to use. Minor changes were
made after reviewing the first two articles, and no further
changes were considered necessary after reviewing the third
article. Data were then extracted using the form by a single
reviewer (CF or CES). A second reviewer randomly selected
four articles (i.e., 25%) and reviewed the data extracted (CF or
CES). As there were no discrepancies, data extraction by a
second reviewer for the remaining articles was considered
unnecessary.
Methodological review
Methodological quality was assessed independently by two
reviewers (CES andMMor CF and AF) using an existing tool
[31]. Minor modifications to the tool were made to reflect
current best practice recommendations regarding confounders
in randomized trials [32, 33] and practical considerations sur-
rounding blinding in psychological and health service re-
search. Specifically, the risk of bias for confounding was
based on whether likely confounders were accounted for at
randomization or during data analysis, regardless of
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differences in participant characteristics at baseline. As
blinding is difficult in this area, studies were given a ‘moder-
ate’ rating by default [34]. Additionally, bias relating to drop-
out was assessed based on the immediate post-intervention
follow-up rather than the final data collection point. This
was to ensure that studies containing multiple follow-up
points were not systematically rated as more biased compared
to studies only reporting immediate post-intervention out-
comes. Bias relating to data collection methods was assessed
based on the primary outcome of interest for randomized con-
trolled trials and for the main acceptability outcome measure
for all other designs. All discrepancies were resolved by
consensus.
Outcomes
The following study integrity and recruitment feasibility out-
comes were assessed: (1) the number of participants to enter
the study, (2) reported recruitment obstacles, (3) representative
samples, (4) if the intervention was implementation as
intended, and (5) cost of implementation. Acceptability out-
comes assessed included (1) intervention adherence rates; (2)
assessments of participant engagement, acceptability, and ap-
peal; (3) any intervention burden; and (4) number of adverse
events. As with previous research, a 40% recruitment rate,
70% retention rate, and a 70% average attendance rate were
deemed acceptable cut-points to assess feasibility [11, 35].
Outcomes relating to efficacy were varied and depended on
the focus of the intervention. In each case, the change in sup-
portive care outcome relative to the comparison group was
reported. Efficacy outcomes were reported for randomized
controlled trials (RCTs) only. Current availability of online
interventions was determined by visiting the study URL, if
included in the study, or by web search.
Results
Study selection
A flowchart of the study selection process is presented in
Fig. 1. A total of 1269 publications were identified from all
sources. After removal of duplicates, 1089 titles and abstracts
were screened, of which 64 were included in the full-text
review. Of those, 16 studies were identified as eligible and
included in full data extraction for this review.
Risk of Bias
Findings from the methodological review are presented in
Table 1. Based on assessments from two reviewers, two of
the studies [36, 37] received a global rating of Bstrong,^ eight
of the studies received a global rating of moderate [26, 35,
38–40, 43, 45, 48], and six received a global rating of Bweak^
[25, 41, 42, 44, 46, 47]. Studies with a weak rating tended to
be small-sample single-arm studies designed to obtain prelim-
inary insights into feasibility and acceptability.
Study characteristics
This review included 16 primary study papers [25, 26, 35–48]
and a further 16 associated papers describing pilot studies,
evaluations, and prior research that informed the primary pa-
pers [12, 15, 49–61]. Included studies were conducted in six
different countries (11 in USA [25, 35–37, 40–43, 45–47], one
each in Australia [48], Canada [39], France [38], Germany
[44], and Norway [26]). Ten of the 16 studies were classified
as RCTs [25, 26, 35–37, 40, 41, 45, 47, 48]; however, one did
not report any efficacy outcomes [41]. The remainder com-
prised of pre/post-test cohorts [39, 42, 43, 46], and a single
study using a two-group quasi-experimental design [44] and
one single group evaluation [38]. Study duration ranged from
less than 1 h to 1 year.
Fifteen studies exclusively targeted men with prostate can-
cer [25, 35–48]; one study included both breast and prostate
cancer examined separately [26]. The total number of men
with prostate cancer in all studies was 2446. Eleven studies
included men with localized prostate cancer [36–43, 45, 46,
48], one with advanced/metastatic disease [35], and four were
either unknown or did not report stage information [25, 26, 44,
47]. Treatment types reported were active surveillance [43],
surgery [26, 38, 44–48], radiotherapy [26, 45, 46, 48], hor-
mone therapy [26, 35], and not yet had treatment [36, 37,
39–42]; one study did not report treatment type [25].
Detailed information on the study characteristics can be found
in Table 2.
Intervention characteristics
Six of the evaluated studies were one-time interventions de-
signed to improve knowledge and reduce decisional conflict
prior to clinician visits [36, 37, 39–42]. Two interventions
were designed to replace office visits; one 1-time Bvideo visit^
with the urologist [47] and one online medical record inter-
vention, where patients could review their record and report
symptoms for their doctor to review [38]. One 5-week inter-
vention aimed to reduce uncertainty and increase self-care
management among men during active surveillance [43].
Another 5-week intervention had men participate in one
counseling session per week with the purpose of improving
mental health [44]. An 8-week intervention for couples was
designed to increase symptom management and communica-
tion skills [46]. A number of interventions aimed to improve
one or more aspects of QoL and reduce distress; one 6-weeks
[25], two 10-weeks [35, 48], one 12-weeks [45], one 1-year in
length [26].
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All interventions used some form of targeted or tai-
lored education [25, 26, 35–48], nine had expert in-
volvement in the form of feedback or counseling [26,
35, 38, 43–48], three had interactive exercises or home-
work to complete [45, 46, 48], three had self-tracking
for symptoms which would be evaluated by a health
care practitioner [26, 38, 47], seven had aspects of social
support in the form of chat groups, communication skill
building, or videos [25, 26, 38, 41, 43, 46, 47], seven
taught stress reduction or coping techniques [35–37, 41,
43, 45, 46, 48]. The majority were website-based inter-
ventions with one study using video conference to de-
liver the study instead [47], one incorporating CD-ROM
options [41], and one delivered specifically via tablet
using video conference [35]. Very few studies specified
following a theory or framework when developing their
interventions. Two studies indicated self-regulation theo-
ry guided them [40, 41] and two others indicated they
structured the intervention following Cognitive Behavior
Therapy frameworks [35, 48].
Fig. 1 Prisma flow diagram
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Feasibility and acceptability
Based on previous research among cancer patients [11, 35],
six studies did not meet acceptable recruitment rates of 40%
[25, 35, 38, 44, 45, 47], while three did not meet acceptable
retention rates of 70% [43–45]. The average recruitment rate
of 15 studies was 54% (ranging from 5 to 95%); one study did
not report a response or recruitment rate [45]. The average
overall retention rate was 78% (ranging from 31 to 100%).
Of the 16 studies included, 9 reported a recruitment goal [26,
35–37, 41, 43, 44, 47, 48], of which 3 studies indicated meet-
ing their goal [26, 37, 47]. Seven studies reported problems
with recruitment [25, 36, 41, 43, 44, 46]. Potential reasons for
recruitment issues were reported to be having a small number
of men to sample from within a urological practice [43], too
stringent eligibility criteria [25], wariness of technology [25,
44], burden of time commitment at stressful time [41], and call
center recruitment issues [41]. In addition, one study indicated
a large number of participants were lost after baseline mea-
sures due to long wait times getting the study started [44]. Few
studies made any mention of implementation costs [25, 26,
38]; only one indicated the monetary cost of implementing the
study [38]. Overall, the majority of studies required at least
basic administrative time andmaintenance on the part of either
the researchers or the health care professional. Five studies
reported intervention URLs [25, 26, 38, 44, 48] of which
two [25, 44] were still active at time of data extraction.
Detailed information on study feasibility can be found in
Table 2.
Due to the variety of study designs apparent, intervention
adherence was not assessed across all studies. Eight studies
reported a percentage of participants that adhered in some way
to the study parameters; the average Badherence rate^ being
68% [35, 39, 41, 42, 45–48]. Outcomes of study adherence
reported included participation in online sessions or modules
[35, 43, 44, 47, 48], completing Bhomework^ or extra mod-
ules [35, 45, 46], using a decision aid to completion [39], and
sharing a decision aid summary page with a health care pro-
fessional [39]. Usage data collected included time spent on a
website, chat group or with a decision aid [35, 41, 44, 46, 59,
61], number of visits to a program or website [26, 38, 41, 43,
45, 46], and number of messages sent to health care provider
or posted on a forum [26, 38, 48].
Most studies included one or more general measure of par-
ticipant satisfaction [25, 35–39, 41, 43, 44, 46], with most
participants reporting they were at least moderately satisfied
with the program or intervention. Four studies reported high
satisfaction with the quality of their cancer care rather than the
intervention itself [40, 42, 46, 47]. One study did not report
any satisfaction measures [26]. Four studies indicated that
participants reported some kind of technical difficulty [38,
41, 47, 48], including incorrect data entry [40], absence of
required software [12], general technical difficulties [41, 47,
61], and not knowing how to use the software [41]. No ad-
verse events were reported in any study. Detailed information
on the acceptability of the programs can be found in Table 3.
Efficacy
Efficacy outcomes are reported for RCTs only. Outcomes
assessed included decisional conflict [36, 37, 40], QoL
[25, 26, 35, 48], distress [26, 35, 45], sexual function
Table 1 Risk of bias assessment summary
Author Selection bias Design Confounders Blinding Withdrawals Data collection methods Global rating
Berry (2013) [36] Moderate Strong Strong Moderate Strong Strong Strong
Berry (2017) [37] Moderate Strong Strong Moderate Moderate Strong Strong
Cathala (2003) [38] Weak Weak n/a Moderate Moderate Weak Weak
Davison (2014) [39] Strong Moderate n/a Moderate Weak Strong Moderate
Diefenbach (2012) [40] Moderate Strong Weak Moderate Moderate Strong Moderate
Fleisher (2015) [41] Weak Strong n/a Moderate Moderate Weak Weak
Johnson (2016) [42] Strong Moderate n/a Moderate Weak Weak Weak
Kazer (2011) [43] Weak Moderate n/a Moderate Moderate Strong Moderate
Lange (2017) [44] Weak Moderate n/a Moderate Weak Weak Weak
Osei (2013) [25] Weak Strong Strong Moderate Weak Strong Weak
Ruland (2013) [26] Weak Strong Strong Moderate Moderate Strong Moderate
Schover (2012) [45] Weak Strong Moderate Moderate Strong Strong Moderate
Song (2015) [46] Weak Moderate n/a Moderate Strong Moderate Moderate
Viers (2015) [47] Weak Strong Weak Moderate Moderate Moderate Weak
Wootten (2015) [48] Weak Strong Strong Moderate Moderate Strong Moderate
Yanez (2015) [35] Weak Strong Strong Moderate Strong Strong Moderate
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Table 3 Intervention overview and engagement and acceptability outcomes
Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
Cathala
(2003)
[38]
Objective: test and evaluate
online medical file in lieu of
face-to-face visit
Participants could login to the
EHR to view various hospital
reports.
They could view videos and read
information regarding their
operation and condition.
They could complete sections
that allowed them to track
their PSA levels and their QoL
over time. Any new entries
would trigger an email to the
chosen physician.
First 6 months tracked by the
Bconnection report system^
95% regularly looked at the site
8 (mean) connections per patient
(range 1–22):
2 dialogue zone messages
2 PSA entries
4 QoL surveys
98% satisfied with various site
sections
94% satisfied with medical file
11% had problems accessing the
site
14% reported technical problems
The online medical program
approach was determined to
be useful and acceptable for
those patients requiring
regular follow up.
It overcame geographical
barriers and allowed close
contact between patients and
health professionals, while
also allowing physicians
access to medical files.
Davison
(2014)
[39]
Objective: to prepare and
identify treatment preferences
and reduce decisional conflict
during selection of PC
treatment.
Participants used an online
decisional aid to produce a
summary page intended to be
presented to a clinician before
treatment begins. The
summary identified their
personal preferences around
decisional control, type and
amount of information
wanted, factors influencing
their decision, and their
preliminary treatment choice.
61% shared summary sheet with
a health care worker involved
in care: 35% with urologist
14% radiation oncologist
12% with family doctor
47% with nurse educator
Patients satisfied with amount of
information (96%), type of
information (93%), way
delivered (89%), involvement
in decision (91%), and
treatment choice (96%)
Participants that shared summary
with their HCP were
significantly more satisfied
with the usefulness of the
sheet.
The use of this support aid was
found to be acceptable to
patients, for use at home or in
clinic.
This can assist men with
localized PC to identify the
factors having an influence on
their treatment decision and
provides a means for these
men to share these preferences
and values with their
physician at the time of
treatment discussions.
This simple tool could also easily
be incorporated into clinical
practice in order to guide
treatment discussions
provided by oncology nurses
to the patient group.
Johnson
(2016)
[42]
Objective: to support patients
with shared decision-making
and reduce decisional conflict
for men with newly diagnosed
LPC prior to treatment deci-
sion.
WiserCare was a web-based ap-
plication that provides
education, preference mea-
surement and personalized
decision analysis.
A report was generated that was
included in the patient file to
be reviewed by clinicians
before consultation.
76% of men invited voluntarily
completed the decision
support module
125 patients who clicked on the
link completed the module.
109 (87%) completed the
module and the follow-up
survey
82% mostly satisfied or
delighted with quality of care
97% mostly satisfied or
delighted with explanations of
treatment and procedures
97% mostly satisfied or
delighted with helpfulness of
information
Implementation of the
WiserCare application was
found to be feasible and
improved several important
components of decision
quality for men deciding on
treatment for newly diagnosed
LPC.
Compared to similar patients
who did not participate in
WiserCare, patients who
completed this decision aid
felt more included in and
jointly responsible for their
treatment decisions, and
strongly agreed that treatment
decisions were discussed in
detail by their provider.
Kazer
(2011)
[43]
Objective: to support patients to
improve knowledge and
self-efficacy, and reduce
uncertainty during AS for PC.
Intervention delivered (a) gener-
al information about PC and
AS; (b) cognitive reframing
Average 20 website views per
participant (range 2–40).
4.2 out of 5 for overall
satisfaction of website and
information
The study findings showed
positive trends in acceptability
of the trial. A larger clinical
trial is planned to follow this
pilot.
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Table 3 (continued)
Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
strategies; (c) self-care man-
agement strategies; and (d)
tailored email-based interven-
tions specific to the needs of
each participant.
Lange
(2017)
[44]
Objective: to support mental
health (e.g. reduce distress and
improve QoL) in PC
survivors.
Participated in 5 group-based
online chat sessions
(60–90 min each, once per
week over 5 weeks) led by a
certified psychotherapist with
experience in psycho--
oncology.
Each session had a theme
proposed by the therapist but
open interaction among
participants was also
encouraged.
100% of intervention group
completed the evaluation
session
No report of participant
engagement with chat groups
The frequency and duration of
sessions was Bsufficient^
(scores of 2.06 each).
BLack of interest^ (31%) and
Bdoubting that it could help
me^ (31%) were the most
frequent reasons for
non-participation
Overall positive evaluation of
program (1 = strongly agree;
5 = strongly disagree)
2.44/5 – overall satisfaction with
chat program
2.61/5 – therapist helpful
4.39/5 – had problems with chat
program
3.95/5 – had computer problems
during chat
The study findings indicate that
web based chat groups may
not be an effective way to
decrease PC perceived
distress despite apparent user
acceptance of the intervention.
Study highlighted the difficulty
in recruitment and
engagement of patients even
in a major prostate cancer
center.
Song
(2015)
[46]
Objective: to support patients’
knowledge of symptom
management, communication
skills, and improve QoL in
LPC post-treatment patients.
Couples were provided seven
education modules to review
(two were mandatory, and five
were optional).
Mandatory modules provided
information about how
couples can work as a team
(e.g., communication) and
survivorship issues.
Optional modules focused on the
management of PC-specific
symptoms and general symp-
toms.
No report of participant
engagement in mandatory
modules.
Average number of logins:
2.73 per patient
Average total time spent on
PERC intervention was
41.99 min
Optional modules completed:
77% sexual dysfunction
77% fatigue
76% urinary dysfunction
Overall positive evaluation of
program (1 = strongly
disagree; 5 = strongly agree)
4.41/5 website easy to use
4.14/5 website was interesting
and engaging
3.09/5 satisfied with quality of
information
The study found the intervention
(PERC) was a feasible and
acceptable method of reduc-
ing side effects of PC
treatment-related symptoms
and improving QoL.
Addition, participants rated
PERC as easy to use and
understand, and they found it
to be engaging, high quality,
and relevant.
High usage rates were
encouraging, particularly as
PERC targeted older adults
(with traditionally poor
technology literacy). This
method may be useful for
overcoming geographical
barriers and improving the
convenience of information
access for patients.
Berry
(2013)
[36]
Objective: reduce uncertainty
and decisional conflict during
selection of PC treatment.
The intervention was a treatment
decision aid tool with tailored
information based on
important identified personal
factors, age, race and
ethnicity, decisional control
preferences, and symptoms.
Participants spend time on the
site, engaging with the
education and assessments.
Pre- and post-questionnaires
are minimal.
Baseline session involved
surveys to determine personal
Time to complete average
46 min (range 16 to 69 min)
[50]
(Higher score =more positive)
[50]
4.1/5 overall satisfaction
4.8/5 easy to use
4.7/5 understandability
4.0/5 helpfulness of program
4.0/5 enjoy program
3.7/5 value of information
Current study: 3.7/5 average
usefulness
P3P is a useable and acceptable
decision support system that
can be deployed in a clinical
setting [50]
P3P did not result in higher
preparation for decision
making at 1 month.
Satisfaction with decision was
not associated with
intervention use at 6 months
[51].
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Table 3 (continued)
Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
preferences, factors,
symptoms, decisional conflict,
etc.
Once complete, participants
were randomized to one of
two groups by an algorithm
embedded in the software.
P3P is composed of education
and communication coaching.
This takes the form of text,
graphs, video clips,
infographics, etc. Tailored to
personally relevant factors
assessed at baseline. For
example, if a participant
indicated sexual health a
priority then this would be one
of the first topics discussed.
Post-measures 1-month later
were completed via email or
mail; whichever was pre-
ferred. DC was assessed
again.
Berry
(2017)
[37]
Objective: reduce uncertainty
and decisional conflict during
selection of PC treatment.
Updated from Berry (2013) [36]
to be more appropriate for
lower literacy levels.
Pilot study [59] used eye
tracking to determine Btime to
first fixation^ and Btotal visit
duration^ in mean seconds on
various aspects of the page
(n = 12).
Time to first fixation: M (SD)
Text Bunderstanding statistics^
8.9 (19.5)
Text: YTL
24.1 (19.4)
Infographic
41 (97.9)
Total visit duration: M (SD)
Text Bunderstanding statistics^
39.7 (32.9)
Text: YTL
53.8 (31.7)
Infographic
21.7 (13.7)
(Higher score =more positive)
[59]
4.8/5 ease of use
4.5/5 enjoyment
4.7/5 helpfulness
4.7/5 satisfaction
4.6/5 amount of time
acceptable
4.9/5 understandable
4.5/5 usefulness of info
This aid to shared
decision-making may be
helpful to support men re-
cently diagnosed with LPC.
Diefenbach
(2012)
[40]
Objective: to support patients to
improve knowledge of
treatments, side effects,
self-efficacy, and QoL, and
reduce uncertainty during AS
for PC.
T-PIES: participants were
presented information
according to their preferred
monitoring style (high vs.
low). Education was available
via the library, and they could
ask questions to a clinician
and participate in a support
group. They could also fill out
a decision-making assessment
if they wanted.
79% (72/91) completed post
measures
Total sample (higher
score =more positive)
4.15/5 useful information
4.15/5 satisfactory information
1.48/5 confusing information
UC more likely to report:
information was confusing
(p = .05)
too voluminous (p = .01), made
them more anxious (less
helpful p = .01; calmed nerves
p = .04).
Intervention groups only (no sig
differences between
intervention groups)
(5 = strongly agree)
The implementation of PIES
within a clinical practice was
found to be feasible and
acceptable to patients recently
diagnosed with prostate
cancer.
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Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
NT-PIES: participants had access
to the PIES system as above
but written information was
not tailored to the monitoring
preferences of the user.
3.76/5 information clearly
presented
3.46/5 includes everything I
need
2.57/5 more information than I
want
4.04/5 graphics clear
3.87/5 glossary helpful
3.80/5 library easy to understand
3.98/5 library useful
Fleisher
(2015)
[41]
Objective: to support patients to
improve knowledge of
treatments, side effects, and
promote informed
decision-making for
newly-diagnosed PC patients.
The intervention consisted of
four modules:
Library – text-based information
on a variety of relevant topics
(e.g., what is prostate cancer,
treatment options, clinical tri-
als).
Patient stories – multi-media
testimonials with actual pa-
tients were used and presented
either with video or still pho-
tographs with voice-overs fo-
cusing on relevant issues, in-
cluding treatment choices,
side-effects, and emotional
reactions.
Doctor’s office – video-based
and text-based information on
cancer specific topics and
FAQs as well as video dem-
onstrations of how to com-
municate with providers using
an evidence-based communi-
cation approach.
Notebook – interactive values
clarification tool where pa-
tients could list the pros and
cons of each treatment ap-
proach and rank in terms of
personal values.
96% in intervention group read
the print materials
57% used the website and/or
CD-ROM, of which:
54% used the website only
24% used CD-ROM only
22% used both
79% of website/CD-ROM users,
reported using the V-CIS for
an hour or more
Participants who reported not
using the V-CIS:
21% reported Bno time^ or Btoo
busy^
25% said it was Bnot needed^
41% had technical problems
Objective usage n = 32 (44%)
59% logged on more than once
96% accessed the library
50% accessed the patient story
59% accessed the doctors’ office
40.6% accessed the notebook
Average overall time spent was
70.9 min (SD = 67.6)
Overall satisfaction
(1 = strongly agree; 4 = strongly
disagree)
* significant differences across
projects
1.69/5 increased knowledge⁎
1.80/5 helped me talk to my
doctor⁎
2.01/5 helped with emotional
concerns
2.98/5 made me feel more
anxious⁎
1.84/5 made me feel more
confident⁎
1.87/5 helped make treatment
decisions⁎
1.76/5 information helped me
deal with cancer treatment⁎
1.99/5 information helped me
deal with side effects
2.25/5 helped me deal with
emotional concerns of
recurrence
2.18/5 helped me adjust to life
after treatment
2.06/5 helped me understand my
follow-up care
Feedback from VCIS users
indicated that it significantly
increased their self-reported
knowledge, helped them to
talk with their doctor, lower
anxiety and increase
confidence, and helped make
treatment decisions.
Cancer patients value both print
and eHealth interventions.
Barriers to adoption and usage
remain, such as lack of
perceived need and issues
with technology.
Osei (2013)
[25]
Objective: to support and
improve patients’ knowledge
(of treatments and side effects)
andQoL in patients diagnosed
with PC.
Intervention utilized the online
education and support group -
Us TOO International Web
site.
Participants were asked to
participate in the group at least
three times per week for
6 weeks.
Study did not report actual
usage.
Participation was not defined
therefore it is unclear whether
men had to comment, post, or
just read/view educational
material to be considered par-
ticipating.
Overall program satisfaction
(4-point scale)
Quality of services
75% good or excellent
Received type of services
wanted
89% generally/definitely
Needs were met
21% all needs met, 37% most
needs met
3.01/4 overall satisfaction
Four men made statements about
the need for other prostate
It is unknown as to the
effectiveness of online vs.
face-to-face groups, whether
online support is contraindi-
cated based on specific patient
psychosocial characteristics,
and the role that physicians
play in effectiveness based on
their recommendation.
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Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
cancer patients to get this
information.
Ruland
(2013)
[26]
Objective: to support and
improve patients’ knowledge
and QoL, and lower symptom
distress in patients diagnosed
with PC.
Participants were given access to
WebChoice online
intervention which included:
- assessment component
- tailored symptom self-
management support
- information section
- communication section (forum
and Q&Awith nurse)
- personal diary
Participants were told that they
could use WebChoice as often
they liked during their 1-year
study participation and that
use of the system was entirely
voluntary.
Activity log tracked server
details by ID for participants.
2 reports were generated;
usage and user report.
Usage –within specific period of
time: logins, section visits, to-
tal visit duration, messages
sent, and forum posts.
User – patient use of the system:
section visits, number of
assessments, number of mes-
sages sent, posts, and diary
notes.
PCS (n = 47/66) logged on at
least twice were categorized
as Busers^ [57]
Users used the site 2018 times
(median = 10.0; range 2–593
logons).
Number of visits to sections
(median)
Discussion forum: 1409 (4.0)
Message to nurse: 624 (4.0)
Assessments: 622 (5.0)
Self-management support: 348
(5.0)
Information section: 271 (3.0)
Diary: 308 (2.0)
A Likert scale from 1 (not at all
useful) to 9 (highly useful)
was used to evaluate the
usefulness of information
given to patients. PC specific
data was not provided. [57]
How useful
Self-management interventions
6.1 (1.9)
General information 6.5 (1.7)
Discussion forum 6.4 (1.7)
Answer from nurse 7.6 (1.6)
Of what quality
Self-management interventions
6.5 (1.6)
General information 6.8 (1.6)
Discussion forum 6.7 (1.5)
Answer from nurse 7.6 (1.6)
How easy to understand
Self-management interventions
7.3 (1.5)
General information 7.2 (1.4)
Discussion forum 7.6 (1.4)
Answer from nurse 8.1 (1.3)
The study found WebChoice to
be a promising tool to help
cancer patients better manage
their illness and reduce
symptom distress.
Schover
(2012)
[45]
Objective: to support and
improve patients’ knowledge
of and manage symptoms of
erectile dysfunction, and
improve sexual satisfaction in
PC survivors.
The intervention consisted of
sexual counseling. Couples
were randomized adaptively
to a 3-month WL, a 3-session
face-to-face format (FF), or an
Internet-based format
(WEB1).
A second Internet-based group
(WEB2) was added to exam-
ine the relation between web
site use and outcomes.
3 homework reports required in
each condition.
52% of men and 44% of partners
completed > 75% of the web
site
Participants asked to engage in
the site or attend 3 FF sessions
over 12 weeks.
Unknown homework report
completion rate.
No measures of satisfaction were
included.
The study found the
Internet-based sexual
counseling program for cou-
ples to be as effective as a
brief traditional sex therapy
format in producing persistent
improvements in sexual out-
comes after prostate cancer.
The time required for therapists
to respond to emails was
significantly shorter than time
required to conduct traditional
therapy sessions, suggesting
Internet-based interventions
may be more time- and
cost-effective as well as ac-
cessible to patients.
Viers
(2015)
[47]
Objective: to replace traditional
patient visits and improve
cost, efficiency and patient
satisfaction in PC patients
post-prostatectomy.
VV from home or work with
urologist. A mail-in PSA test
was completed locally before
the appointment.
Patients were evaluated by a
resident or midlevel provider
82% of those randomized to
video appointment completed
it.
No significant difference in
patient satisfaction between
the intervention (remote
visits) and control (office
visits) groups.
BI was pleasedwith the quality of
the medical encounter^
83%/91% strongly agree
intervention/control (p = .41)
BI believe that the medical
encounter was conducted in a
The majority (96%) of patients
undergoing VV would
participate in this type of
encounter again.
For established patients, this
model could be applied across
multiple urologic indications
and clinical scenarios.
VV timings improved across all
measures throughout the
course of the trial, with only
J Cancer Surviv
Table 3 (continued)
Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
and a staff urologist. If a
physical examination was
indicated, a follow-up clinic
appointment was provided.
confidential manner^
88%/100% strongly agree
intervention/control (p = .09)
BI was overall satisfied with
appointment today^
88%/91% strongly agree
intervention/control (p = .70)
two technical failures early in
the study.
Funding and credentialing
limited the size of the study
population. ~70% of
physicians reported that
credentialing is a significant
setback to the implementation
of telemedicine.
Wooten
(2015)
[48]
Objective: to support patients to
improve their knowledge and
reduce psychological distress
in LPC patients undergoing
treatment.
Self-directed CBT-based inter-
vention provided psycho--
education, a series of interac-
tive exercises and regular
feedback.
Intervention was a 6-module on-
line program for participants
to work through at their own
pace over 10 weeks.
The six modules focused on:
1. The emotional impact of
prostate cancer
2. Cognitive strategies and
effective communication
3. Coping with the physical
challenges relating to prostate
cancer
4. Sexuality and masculinity
5. Sexuality and intimacy
6. Planning for the future
59% (mean) content completed
MRA only group = 60%
MRA+ forum group = 57%
Completion rates dropped as
participants moved through
modules.
On average participants
completed:
87% module 1, 72% module 2,
60% module 3, 56% module
4, 41% module 5, 36% of
module 6
Forum participation was higher
for Forum alone group (avg.
2–3 posts per user) than
MRA + forum (avg. 1–2 post
per user)
69% of participants reported
spending < 30 min per week
on the forum.
Overall satisfaction n = 26 [61]
48% satisfied with intervention
78% would recommend
Forum satisfaction
41% satisfied with forum
66% said easy to use
38% said other men’s posts were
helpful
31% said moderator posts were
useful
As a result of these findings and
qualitative feedback from
users and technical
consultants, changes were
implemented in the larger
included study. However,
satisfaction results have yet to
be published.
The intervention was received
positively by participants in
the pilot study.
Feedback indicated good
acceptability of the
intervention.
Some technical and participant
engagement issues were
identified and changes were
implemented as a result of the
pilot testing.
The included study highlights
the potential to deliver support
for men with PC.
Yanez
(2015)
[35]
Objective: to support patients to
ease their symptom burden
and improve QoL in advanced
PC patients.
Intervention delivered via a
web-based platform on a tab-
let by a group facilitator with
video conferencing software.
Intervention aims included
developing stress awareness,
learning stress reduction
skills, changing negative
stressor appraisals,
developing coping skills,
building interpersonal skills,
and building or enhancing
social networks.
The website contained review
materials of the principles of
cognitive behavioral stress
management (discussed
during the weekly group
meetings), as well as audio
recording of relaxation
CBSM-intervention group
attended 6.59/10 sessions
(SD = 3.35)
HP-control group completed
8.22/10 (2.75) sessions
CBSM-intervention group
completed 4.84 (3.35) weekly
assessments
HP-control group completed
7.05 (3.14) weekly
assessments
During the first 30 min of each
group session, CBSM
participants practiced a new
stress reduction/relaxation
technique. During the last
60 min, the focus was on
stress management.
No between group difference in
exit survey scores (4-items).
4-point scale (higher
numbers = more positive)
Questions: mean (SD)
In general, how much did you
like the information presented
in the weekly online reviews?
CBSM: 3.65 (0.49)
HP: 3.40 (0.76)
In general, how much did you
like the information presented
in the online expert videos?
CBSM: 3.66 (0.50)
HP: 3.46 (0.52)
In general, how much did you
like the weekly online groups?
CBSM: 3.40 (0.83)
HP: 3.68 (0.69)
In general, how much did you
like the online relaxation
exercises?
CBSM: 3.81 (0.40)
HP: N/A
Findings generally support the
feasibility, acceptability and
preliminary efficacy of this
CBSM psychosocial
intervention for men with
advanced prostate cancer.
Participants in HP condition
were more likely to attend
study sessions than
participants in the CBSM
condition.
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and satisfaction [45], relationship satisfaction [45], health
care provider visit efficiency [47], psychological distress
[48], depressive symptoms [26, 35], social cognitive out-
comes [26], cancer-related symptoms [25], and treatment
preferences [40]. Of the nine RCTs reporting efficacy out-
comes, three reported significant improvements in the pri-
mary outcome relative to the control [25, 40, 48]. In ad-
dition, two reported a significant intervention effect on a
subscale of the primary outcome [26, 36], and one report-
ed significant intervention effects on secondary outcomes
[37]. One study reported improvements in the primary
outcome among all intervention groups, resulting in no
significant difference between groups [45]. Of the remain-
ing studies, three reported no significant intervention ef-
fects compared to the control group (which included face-
to-face visits in most cases [35, 47]) and one did not
report efficacy data [41]. Detailed information on the ef-
ficaciousness of the interventions can be found in Table 4.
Decision making
Participants who received decision aids were more satisfied
with their care and treatment decisions than those receiving
standard care [36, 37, 39–42]. Three studies reported complet-
ing decision aids increases in self-reported knowledge, more
confidence in their decision, and decreased uncertainty and
decisional conflict compared to usual care [36, 37, 40, 41].
Participants that received a decision aid were less likely to be
anxious about their decisions [40, 41]. Two studies reported
that decision aids reduced distress [40, 41].
Quality of life
Participants that participated in an online support chat group
reported improvements in QoL over time after treatment-
related declines [25]. Participants that accessed a supportive
online intervention reported improvements in QoL measures
but not significantly different from the control group [26].
Access to cognitive behavioral therapy-based intervention on-
ly had an improvement in outlook compared to the forum
groups. Those in the therapy group with forum access had
reductions in regret compared to the forum only group indi-
cating positive impact on PC-related QoL [48].
Sexual health
Participants that received internet-delivered sexual counseling
had similar improvements in erectile function compared to
face-to-face counseling [45] with no significant difference be-
tween the groups.
Mental health
Participants receiving access to an online supportive care in-
tervention had improvements in depression measures [26].
Those that had access to a cognitive behavior therapy-based
intervention had significantly better improvements in psycho-
logical distress than those with access to a chat forum only
[48]. Another study that delivered cognitive behavioral stress
management found no difference in cancer-related distress
between groups but a trend toward reduced depressive symp-
toms in intention-to-treat analyses [35].
Visit efficiency
Studies that examined using online follow-ups or visits rather
than face-to-face were also well received by participants [38,
47]. One study examined the efficiency and cost-effectiveness
of video visits with an urologist rather than office visits and
found no significant difference in any timingmeasure between
the groups and estimated significantly less cost associated
with the video group [47]. One study reported the amount of
time for therapists to respond to email queries was less than
time taken to conduct traditional therapy sessions [45].
Table 3 (continued)
Source
(author and
year)
Objectives and description of
intervention
Engagement (usage) Acceptability (satisfaction) Conclusions
strategies (e.g., guided
imagery) that participants
were encouraged to review
and practice on a weekly
basis.
EHR electronic health record, PSA prostate specific antigen, PC prostate cancer, HCP health care provider, LPC localized prostate cancer, AS active
surveillance, PERC Prostate Cancer Education and Resources for Couples; P3P: Personal Patient Profile – Prostate,DC decisional conflict, YTL years to
live, PIES prostate interactive education system, T-PIES tailored PIES, NT-PIES non-tailored-PIES, UC usual care, V-CIS virtual cancer information
service, WL wait-list, FF face-to-face, OV office visits, VV video visits, CBT cognitive behavioral therapy, MRA My Road Ahead, CBSM Cognitive
Behavioral Stress Management, HP health promotion, QoL Quality of Life
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Table 4 Summary of RCT results reporting study efficacy outcomes
Source Design Outcomes measured Efficacy results Conclusions
Berry
(2013)
[36]
2-arm RCT (n = 494)
Decision aid tool vs attention
control.
Attention control given a list of
reputable websites to review
in the same time period as the
intervention group.
Primary: decisional
conflict subscales
including: uncertainty,
informed, values clarity,
and support.
Secondary: PC with
decision at 6 months
completed effective
decision and total score.
Primary
• Significantly less uncertainty (p = .04)
and lack of values clarity (p = .002)
in intervention group.
• Subscales effect sizes: uncertainty:
− 3.61 (− 7.01, − 0.22); lack of values
clarity: − 3.57 (− 5.85, − 1.30)
Secondary
• No difference in total DC score
between groups (p = .07).
• Estimation of group study effect
(coefficient (95%CI)): Total score
− 1.75 (− 3.61,0.11); p = .07
Findings support efficacy of the P3P
intervention for addressing
uncertainty and facilitating selection
of a treatment.
P3P did not result in higher preparation
for decision making at 1 month.
Satisfaction with Decision was not
associated with intervention use at
6 months [51].
Berry
(2017)
[37]
2-arm RCT (n = 392)
Decision aid tool vs. attention
control.
Attention control given a list of
reputable websites to review
in the same time period as the
intervention group.
Decision aid updated from
Berry (2013) to be more ap-
propriate for lower literacy
levels.
Primary: total score on
modified low literacy
decisional conflict scale
(reported at baseline
and 1 month)
Multivariate model: (LS mean
(95%CI); p)
• P3P vs. control: − 5.0
(− 9.40, − 0.59); p = .003
• Lower income: 8.69 (4.43, 12.96);
p < .0001
• Having made no decision at 1 month:
20.11 (16.10, 24.13); p < .0001
• Lower D’Amico risk: 4.29
(0.80, 7.78); p = .02
Had ≥ 2 consults: 6.04
(1.83, 10.26); p = .0005
• EUH site: 11.02 (3.49, 18.56); p = .02•
Interactions:
Marginal significance for group and
marital status (p = .06) with single
men in P3P having lower DC.
Marginal significance for number of
consults by group (p = .07) with those
in control group having < 2 consults
having higher DC scores.
P3P demonstrated a beneficial effect for
men with LPC in a multi-institutional
sample as they engaged in
decision-making for the management
of the cancer.
Other variables impacted conflict and
modified P3P’s effect, notably risk
level and men’s resources.
Diefenbach
(2012)
[40]
3-arm RCT (n = 72)
T-PIES vs. NT-PIES vs. UC.
T-PIES: information given
according to preferred style
of monitoring, and
opportunity to ask clinicians,
and a support group.
NT-PIES: as above but written
information not tailored to
monitoring preferences.
UC: attention control given NCI
brochures to read in the same
period as the intervention
groups.
Primary: treatment
decisional measures
Secondary: psychological
distress, treatment
preferences
No difference between T-PIES vs.
NT-PIES therefore PIES groups were
combined for these comparisons vs
control.
PIES groups were significantly more
confident in their treatment decision
vs control.
(Mean (SD): higher score better)
UC: 3.22 (1.32) vs. PIES: 3.85 (1.022);
p = .02
PIES groups less likely to report needing
more information vs control.
(Mean (SD): lower score better):
UC: 3.44 (1.54) vs. PIES:
2.52 (1.49); p = .02
3 groups analyzed: UC vs.
T-PIES vs. NT-PIES
Helpful in decision-making
(higher is better)
UC: 1.79 (0.92) vs. T-PIES: 4.29 (0.64)
vs. NT-PIES: 4.10 (1.07); p = .01
Calmed nerves about decision
(higher is better)
UC: 2.68 (1.06) vs. T-PIES: 3.12 (0.83)
vs. NT-PIES: 3.46 (0.89); p = .04
Made more anxious about decision
(lower is better)
UC: 3.62 (1.05) vs. T-PIES: 2.45 (1.09)
vs. NT-PIES: 2.40 (1.27); p = .03
PIES improved key decision-making
process variables (e.g., knowledge of
treatments and side effects), as well as
increasing confidence in and reducing
the emotional impact of a treatment
decision making.
No additional benefit to tailoring
information to delivery style in the
two intervention groups.
Osei (2013)
[25]
2-arm RCT (n = 40) Primary: QoL (general and
cancer specific, life
MANOVAs mean differences
across time
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Table 4 (continued)
Source Design Outcomes measured Efficacy results Conclusions
Online education and support
group - Us TOO
International Web site.
Control group was given PC
resource kits.
Participants were asked to
participate in the group at
least three times per week for
6 weeks.
satisfaction,
relationship
satisfaction)
Secondary: prostate
cancer-specific symp-
toms
No statistically significant effects of age
and/or group but there was a signifi-
cant (p = .036) time*group interaction
across all ten measures included in a
global QoL measure uniquely con-
structed for this study.
Trend was for a drop in QoL at midpoint
measure (6 weeks) with a return to
initial levels at post measure.
Variables affected included:
perceived physical health (p < 0.001)
urinary irritation and obstruction
health (p < 0.019)
sexual health (p < 0.001)
hormonal health (p < 0.001)
life satisfaction (p < 0.001)
spouse negative characteristics
(p < 0.030)
The results suggest that online support
groups can have a positive effect on
perceived QoL of men.
Ruland
(2013)
[26]
2-arm RCT (n = 325 overall;
136 PC)
Intervention group (WebChoice
users) vs. control (URLs of
reputable websites)
Primary: symptom distress
Secondary: depression,
self-efficacy,
health-related QoL, so-
cial support
Note: efficacy outcomes were not
reported separately for breast
vs. PC survivors.
Reporting when applicable: slope
estimate (95%CI); t; p
• No between group difference in overall
MSAS-SF score (p = .19)
• No between group difference in
psychological symptoms scale
(p = .11) or physical symptoms
scale (p = .09)
• Significant between group difference in
GDI: − 0.059; (− 0.101, − 0.004);
t = 4.42; p = .037
• Within-group improvements in depres-
sion for intervention group: − 0.41;
(− 0.71, − 0.11); t = − 2.71; p = .007
• Within group decrease in self-efficacy
for control group: − 3.77; (− 6.38,
− 1.15); t = − 2.82; p = .005)
•Within group decrease in health-related
QoL for control group: − 0.01;
(− 0.01, − 0.00); t = − 2.77; p = .006
That WebChoice is a promising tool to
help cancer patients better manage
their illness and reduce symptom
distress, is partially supported by the
data.
The secondary outcomemeasures did not
show significant differences between
study groups with respect to
depression, self-efficacy,
health-related QoL, and social
support, however the benefits of
WebChoice were still quite respect-
able.
High use of symptom assessments,
advice, and the discussion forum was
associated with high levels of
symptom distress [52].
Schover
(2012)
[45]
3-arm RCT (n = 182)
3-month waitlist (WL) vs.
3-session face-to-face format
(FF) vs. 3 session
internet-based format
(WEB1).
A second internet-based group
(WEB2) was added.
Primary: erectile function
for PC; female sexual
function for partners.
Secondary: emotional
distress, relationship
satisfaction
No significant changes in outcome
measures during WL period
Significant gains in IIEF for all men
between baseline and 6 months
(p < .0006) and 1-year (p < .0046)
follow-up for erectile function.
IIEF scores: p value, Cohen d:
• FF across time p < .0001, d = 0.35
• WEB1 across time p = .004, d = 0.35
• WEB2 across time p = .0096, d = 0.27
No difference between groups (FF vs.
WEB1 vs. WEB2) at follow-up for
erectile function.
The internet-based sexual counseling
program was found to be as effective
as traditional face-to-face counseling
for improving sexual outcomes in
prostate cancer survivors.
Viers
(2015)
[47]
2-arm RCT (n = 70)
Remote video visits (VV) from
home or work with urologist
vs. traditional office visits
(OV).
Primary: visit efficiency
(measured by time)
Secondary:
patient/provider
satisfaction, cost of
visits
No difference between groups in (VV
mean vs. OV mean; (95% CI); p):
• Total time in minutes devoted to patient
care: 17.9 vs. 17.8; (− 5.9, 5.6); p = .97
• Total patient face time in minutes: 14.5
vs. 14.3; (− 5.4, 5.2); p = .96
• Patient–staff face time in minutes: 12.1
vs. 11.8; (− 4.2, 3.5); p = .85
• Patient waiting time in minutes: 18.4 vs
13.0, (− 13.7, 3.0); p = .20
VVs had equivalent timing efficiency,
similar patient satisfaction, and
significantly reduced costs when
compared to OVs.
Specifically, VVs were associated with
reductions in distance traveled, travel
time, missed work, and money spent.
A learning curve for the use of VV is
present, but further investigations are
needed.
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Discussion
The aim of this systematic review was to examine the feasi-
bility, acceptability, and efficacy of online supportive care
programs for men with prostate cancer. Overall, the results
showed that using online delivery can be feasible and accept-
able to men with prostate cancer; however, the field is still in
its infancy. We found 16 studies that met our criteria among
which 10 were randomized controlled trials. The results
showed trends toward the programs being efficacious; how-
ever, among these trials, few were large enough to make
meaningful conclusions on the efficacy of online supportive
care programs, and selection bias was a consistent issue.
Though the average recruitment rate was 54%, only three
of seven studies reporting recruitment goals met their goals.
Recruitment is often a challenge in research studies among
cancer survivors, particularly those targeting men [12, 62].
Collaborating with other centers to conduct multicenter trials
may help to improve this to some extent. As well as increasing
the recruitment pool, this may also help to recruit more repre-
sentative samples, by ensuring participants are recruited from
different geographical locations [63]. Another option would
be to use multimodal recruitment strategies, such as social
media ads combined with clinic-based recruitment as this
has been shown to have similar advantages [26, 48]. As the
majority of studies reviewed in this paper suffered from selec-
tion bias it is likely that the included sample is not entirely
representative of the intended target group. Acceptability and
efficacy findings should be interpreted with this in mind. In
this sense, these results indicate that using online delivery for
supportive care programs is feasible and acceptable, at least in
some sub-groups of men with prostate cancer.
Table 4 (continued)
Source Design Outcomes measured Efficacy results Conclusions
Linear regression analysis of timing data
revealed a downward trend in timing
parameters for the VVarm, however,
not statistically significant (p = 0.07)
VV group had significantly lower
estimated costs including (all
p < 0.0001):
• distance traveled (median 0 vs.
95 miles)
• travel time (0 vs. 95 min)
• work missed (0 vs. 1 day)
• money spent ($0 vs. $48)
Wooten
(2015)
[48]
3-arm RCT (n = 142)
MRA only vs. MRA+ forum vs.
forum only
Primary: psychological
distress (DASS-21)
Secondary: prostate
cancer-related QoL,
confidence
Pairwise comparisons
• Psychological distress: MRA+ forum
(↓) vs. forum only (↑): − 8.8 (− 16.7,
− 0.9); p = 0.02
• Informed decision: MRA only (↑) vs.
MRA+ forum (↓):15.3 (0.8, 29.8);
p = 0.03
• Regret: MRA+ forum (↓) vs. Forum
only (↑): − 8.1 (− 16.1, − 0.1); p = 0.04
• Outlook: MRA only (↑) vs. Forum
groups (↓): 17.2 (2.9, 31.4); p = 0.01
A statistically and clinically significant
improvement in psychological distress
was seen for participants who had
access to both the online intervention
and moderated forum, while no
significant change in psychological
distress was seen for the other two
intervention conditions.
Yanez
(2015)
[35]
2-arm RCT (n = 74)
CBSM (cognitive-behavioral
stress management) inter-
vention vs. health promotion
attention control
Acceptability (main
outcome detailed in
Table 3)
Secondary: cancer-related
distress (IES-R), de-
pressive symptoms,
health-related QoL
CBSM mean vs. HP mean; p
Completers
Cancer-related distress: 8.39 vs. 10.20;
p = .48
Depression: 43.37 vs. 47.29; p = .03
FACT total: 88.32 vs. 84.03; p = .17
Intention-to-treat
Cancer-related distress: 8.46 vs. 9.86;
p = .56
Depression: 44.04 vs. 47.13; p = .06
FACT total: 87.95 vs. 85.39; p = .39
Participants in HP condition were more
likely to attend study sessions than
participants in the CBSM condition.
Although the sample size was
underpowered effect sizes suggest the
CBSM may have contributed to
reduce depression more and reduce
QoL more than control.
PSA prostate specific antigen, PC prostate cancer, HCP health care provider, LPC localized prostate cancer, AS active surveillance, PERC Prostate
Cancer Education and Resources for Couples, P3P Personal Patient Profile – Prostate, DC decisional conflict, EUH Emory University Hospital, YTL
years to live, PIES prostate interactive education system, T-PIES tailored PIES, NT-PIES non-tailored-PIES, QoL Quality of Life, NCI National Cancer
Institute, MSAS-SF Memorial Symptom Assessment Scale-Short Form, GDI global distress index, UC usual care, V-CIS virtual cancer information
service,WLwait-list,FF face-to-face, IIEF International Index of Erectile Function,FSFI Female sexual function index,OVoffice visits,VV video visits,
CBT cognitive behavioral therapy, MRA My Road Ahead, CBSM Cognitive Behavioral Stress Management, HP health promotion, IES-R Impact of
Event Scale–Revised, ANOVA analysis of variance, ANCOVA analysis of covariance, MANOVA multiple ANOVA
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Despite the growing body of literature investigating online
methods of providing patient support, we found only 16 stud-
ies met our inclusion criteria. There was little research among
men with prostate cancer despite there being evidence of in-
terest in supportive care programs among this population [16,
64, 65]. Furthermore, a large portion of the studies were test-
ing decision aids for men who had localized prostate cancer
and were yet to have any treatment. As one study points out,
guidelines from the American Urological Association indicate
that shared decision making is an important component of
treatment counseling for men with localized disease [37].
These aids were seen as beneficial for men in increasing their
knowledge about prostate cancer treatments and what treat-
ment may be right for them, thereby reducing decisional con-
flict and regret. Only one study focused onmenwith advanced
prostate cancer [35]. This restricts the generalizability of the
conclusions to men with less severe forms of cancer.
While assisting men with prostate cancer to make informed
treatment decisions is an important area of research, there are
aspects of cancer care that have yet to be comprehensively
addressed in this population. One area that warrants further
attention in particular is the delivery of behavior change sup-
port. The studies included in this review focused mainly on
psychological aspects of well-being, such as reducing distress,
improving stress management and communication skills, and
relationship satisfaction. However, activity levels, diet, and
sleep behavior also impact QoL (both overall and disease
specific) across the cancer continuum [66–70]. Structured ex-
ercise and physical activity in general have been shown to
counteract prostate cancer related treatment toxicities, reduce
disease progression in those with early stage disease, as well
as improve psychosocial outcomes, and increase men’s sense
of empowerment and control [69–72]. Additionally, online
programs targeting physical activity and diet have been shown
to be efficacious in other groups of cancer survivors [73]. It
may be the case that interventions which encourage behavior
change, such as physical activity, diet, and/or sleep, may be
more effective and appealing to men than traditional psycho-
logical support, given that the outcomes (particularly those
associated with exercise) often align with traditional mascu-
line values [70]. However, additional high-quality research,
particularly in prostate cancer, which assesses these outcomes
objectively and longitudinally are required to not only estab-
lish their efficacy in targeting behavior change, but also sup-
portive care needs [24, 73].
Summarizing results was difficult among the included
studies as even those that focused on similar outcomes had
measured or reported them differently. In addition, reporting
of methods was lacking in many of the studies. As noted in
Table 1 that summarizes the methodological review, only one
study received a strong rating, five ranked weak and the re-
maining ten were ranked moderate. In order to grow this area
of research, methods need be rigorously documented, as
previous reviews have suggested [12, 14, 15, 62]. Lessons
learned from previous research can greatly impact the body
of literature by ensuring future studies build on what has been
done previously.
While this study has been the first to summarize online
supportive care interventions for men with prostate cancer,
there are some study limitations that need to be mentioned.
We understand that including only studies published in
English reduced potential access to the total number of glob-
ally published studies. Furthermore, this study contained a
high proportion of one-time clinical treatment decision sup-
port tools, and most studies had small samples or were pilot
trials. This reflects the lack of variety of studies available,
likely due to the infancy of this field and known issues with
recruitment. Strengths of this study include a-priori protocol
registration, the use of a standardized data-extraction form, the
depth and range of data extracted, and synthesized and cor-
roboration and consensus between a number of researchers
during the data extraction and bias tool implementation. This
allowed balanced assessments in which studies were fairly
examined during the extraction and quality assessment stages
of the review.
Aligned with previous research, we see a need for rigorous
study development and reporting [11]. Methodological quality
was generally weak mainly due to underreporting of methods.
In order to build on or replicate results, clear description of the
intervention components is necessary. Additionally, future re-
search should ensure usage and adherence of individual inter-
vention components are well reported. The majority of studies
in this review included patients with localized disease. To ad-
dress these research gaps, more focus should be on men with
advanced disease and their specific supportive care needs.
Online supportive care may be particularly useful for clini-
cians as both decision aids and as a tool for patient follow-up.
Many decision aids were able to be completed while waiting
for a clinician or at home before an appointment. This allows
men time to thoroughly examine the information and by shar-
ing a report with their clinician, be more involved in the deci-
sion-making. For clinicians, this means less time devoted to
treatment explanation in appointments and an increased feel-
ing of shared decision making. Additionally, more than one
study indicated that using online methods of follow-up, when
possible, was just as efficient as office visits [25, 38, 47].
Clinicians spent the same, or fewer, minutes interacting with
patients with no perceived reduction in quality of care. These
methods may be more cost-effective for both clinicians and
patients.
This review provides preliminary evidence in modest sup-
port of online supportive care programs for men with prostate
cancer. Our conclusions are limited by the small number and
weak methodological quality of studies found. A consistent
call for well-documented, rigorously conducted studies has
been noted in previous reviews and is echoed here.
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